Navigation Links
Mylan's Matrix Receives WHO Approval for First Generic, Heat-Stable Version of HIV Protease Inhibitor
Date:2/25/2009

Provides first affordable protease inhibitor for patients in developing countries

PITTSBURGH, Feb. 25 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds a 71.5% controlling interest, received the first and only World Health Organization (WHO) approval for Lopinavir/Ritonavir Tablets, 200 mg/50 mg. Matrix's version of this product is heat-stable and affordable, making it practical for distribution and use in warm climates.

Lopinavir/Ritonavir Tablets are the generic version of Abbott Laboratories' Kaletra(R) Tablets, the brand marketed in the U.S. and Europe, and Alluvia Tablets, the brand marketed in the developing world. It is used in combination with other medications to control HIV infection and is included in the antiretroviral (ARV) class of drugs known as HIV protease inhibitors.

Mylan Vice Chairman and CEO Robert J. Coury said: "Mylan and Matrix are committed to our growing and high quality ARV franchise. Our goal is to provide HIV treatments to patients around the world -- especially in developing countries. With Matrix's heat-stable and affordable version of Lopinavir/Ritonavir, patients in remote parts of developing nations now have access to this important medicine."

A WHO approval indicates that a drug meets international safety, efficacy and manufacturing quality standards. With such status, Matrix can sell the treatment in most countries outside the United States and Europe.

Matrix's wide range of ARV products includes active pharmaceutical ingredients (API) and first- and second-line finished doses; patients use second-line therapies if and when they develop resistance to initially prescribed treatments. The company's emphasis on producing affordable products has allowed i
'/>"/>

SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference
3. Collagen Matrix, Inc. Receives FDA 510(k) Clearance for SynOss(TM) Synthetic Mineral Bone Graft Material
4. Matrixx Initiatives, Inc. Updates 2007/2008 Cold Season Trends and Fiscal 2008 Sales and Earnings Outlook
5. Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2008 Financial Results
6. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
7. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
8. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
9. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories
10. Rising Medical Solutions Partners With myMatrixx to Deliver Integrated Pharmacy Management Solutions
11. Matrix registry probes adherence to clopidogrel at 1 year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... According to the new market research report “Micro Irrigation ... published by MarketsandMarkets, global micro irrigation system market expected ... year 2010 and is expected to reach $3,414.7 million ... 2011 to 2016. , Browse:, , ... , 370 pages and in-depth Table Of ...
(Date:5/24/2013)... Pittsburgh, PA (PRWEB) May 24, 2013 ... may be more likely to suffer from gastroesophageal reflux ... physicians reported in a study published today. , ... and Abnormal Proximal Exposure as Measured by Hypopharyngeal Multichannel ... “These findings could be of great importance to individuals ...
(Date:5/24/2013)... 24, 2013 For the second consecutive ... Fresh Express Café to treat Tabitha Meals on Wheels ... their door. More than 400 meal recipients recently enjoyed ... restaurants, along with the rest of a well-balanced, nutritious ... to partner with the Tabitha Meals on Wheels team,” ...
(Date:5/24/2013)... May 24, 2013 With today’s levels of ... hunting for advice on the causes of weight gain and ... developed that suggest causes of weight gain and treatments that ... study was released by the Child Study Center at ... the childhood diagnosis of ADHD and the soring rates of ...
(Date:5/24/2013)... Today marks the launch of Destination Halifax’s latest ... The redesigned and enhanced Itinerary Builder will help visitors ... computer or mobile device that they can send, save, ... to fill in their date of arrival and length ... of vacation packages, accommodations, restaurants, and things to do ...
Breaking Medicine News(10 mins):Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 3Health News:West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough 2Health News:Runza® Delivers Sandwiches, Draws Smiles from Tabitha Meals on Wheels Clients 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Now Help Patients with Weight Gain Linked to Childhood ADHD Lose Weight Fast 2Health News:Create and Win the Perfect Halifax Getaway with the All-New Itinerary Builder 2
... Steve TyrellSpecial Performance by Dancing With The Stars ... actress Bonnie Hunt will receive the "True ... Harvey Rosen will receive "The Duke" ... 24th annual Odyssey Ball. The yearly fundraising ...
... added section on hospital care and advice on drugs ... News) -- New guidelines for treatment of heart failure ... the American College of Cardiology, with a strong emphasis ... also on the treatment of blacks. , "The most ...
... Survey conducted by the Society of Corporate Compliance and ... In the face of reports on AIG bonuses it ... of the gifts employees can give and receive and ... a survey the Society of Corporate Compliance and Ethics ...
... Possis Acquisition and Patient Care Innovations WARRENDALE, Pa., ... over $600 million in 2008, an increase of ... (excluding the effect of the Possis Medical, Inc. ... and therapeutic medical devices, MEDRAD has achieved a ...
... Software Upgrade Enhances Company,s Lead in Data Quality, ... AnalysisPITTSBURGH, March 26 Neuro Kinetics, Inc. (NKI) ... evaluation equipment used worldwide for balance, vestibular and ... release version 6.7 of its proprietary VEST(TM) control ...
... (NYSE Amex: DPW ) today announced its financial ... December 31, 2008.Digital Power reported net income of $142,000 for ... income of $235,000 for the three months ended December 31, ... 2008, compared to operating income of $206,000 for the fourth ...
Cached Medicine News:Health News:John Wayne Cancer Institute Auxiliary Honors Award-Winning Actress Bonnie Hunt and Philanthropists Donna & Harvey Rosen at the 24th Annual Odyssey Ball 2Health News:New Guidelines for Treating Heart Failure 2Health News:New Guidelines for Treating Heart Failure 3Health News:Bonuses May be Big but Don't Expect a Lavish Dinner or Gift 2Health News:MEDRAD(R) Revenues Grow 10 Percent in 2008 2Health News:MEDRAD(R) Revenues Grow 10 Percent in 2008 3Health News:MEDRAD(R) Revenues Grow 10 Percent in 2008 4Health News:Neuro Kinetics to Release VEST(TM) 6.7 Software at Audiology Conference 2Health News:Neuro Kinetics to Release VEST(TM) 6.7 Software at Audiology Conference 3Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 2Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 3Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 4
(Date:5/23/2013)... 2013 3SBio Inc. (NASDAQ: ... China -based biotechnology company focused ... announced today that, at an extraordinary general meeting ... in favor of the proposal to authorize and ... merger dated February 8, 2013, among Decade Sunshine ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 Neurocrine ... Kevin Gorman , President and Chief Executive ... Bank 38 th Annual dbAccess Health Care Conference in ... Thursday, May 30 at 11:20 a.m. Eastern Time / 8:20 ... be accessed on the Company,s website at http://www.neurocrine.com . ...
(Date:5/23/2013)... May 23, 2013 Nephros, Inc. (OTC Bulletin ... device company that develops and sells high performance liquid ... rights offering.  In addition, the concurrent temporary reduction in ... on May 17, 2013. Nephros estimates that ... the rights offering.   A portion of the proceeds will ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... , CONCORD, Calif. , Feb. 3 Pulse Systems ... the Western United States . Effective February 1, 2010 , Diverse ... exclusive sales territory encompassing the states of California (except for the ... Oregon , Washington , Colorado , Utah , Idaho ...
... , VIENNA, Va. , Feb. 3 ... , Chief Executive Officer, will be presenting at the 2010 BIO ... the conference will take place February 8-9 at the ... be on Tuesday, February 9th , at 1:30 p.m. ...
Cached Medicine Technology:Pulse Systems Announces New Sales Representation in the Western United States 2Pulse Systems Announces New Sales Representation in the Western United States 3CEL-SCI to Present at 12th Annual BIO CEO & Investor Conference 2
... Used for stone manipulation and ... Enhanced wire strength permits the ... more readily than standard flat-wire ... easy, ergonomic one-handed operation. Supplied ...
... manipulation and removal in the urinary tract. The ... its shape following extreme torsion. The unique tipless ... the basket to open at the base of ... design reduces the likelihood of mucosal damage and ...
Used to establish and maintain nephrostomy drainage following pyeloplasty. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; stent must not r...
... Analyzer is an in vitro diagnostic ... chemistry parameters using Reflotron Test Tabs. It works ... rapid and reliable results while being easy to ... display and the profile can be printed out ...
Medicine Products: